Vertex Pharmaceuticals Files 8-K on Shareholder Votes
Ticker: VRTX · Form: 8-K · Filed: May 14, 2025 · CIK: 875320
| Field | Detail |
|---|---|
| Company | Vertex Pharmaceuticals Inc / Ma (VRTX) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, regulatory-filing
Related Tickers: VRTX
TL;DR
VRTX filed an 8-K on 5/14 for shareholder votes. All good.
AI Summary
Vertex Pharmaceuticals Incorporated filed an 8-K on May 14, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corporate information, including its address at 50 Northern Avenue, Boston, MA, and its primary business in pharmaceutical preparations.
Why It Matters
This filing indicates that Vertex Pharmaceuticals is engaging with its shareholders on important corporate matters, which could impact company governance and future strategic decisions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of matters submitted to a vote of security holders and does not indicate any immediate financial or operational risks.
Key Numbers
- 000-19319 — SEC File Number (Identifies the specific SEC filing for Vertex Pharmaceuticals.)
- 04-3039129 — I.R.S. Employer Identification No. (Tax identification number for Vertex Pharmaceuticals.)
Key Players & Entities
- Vertex Pharmaceuticals Incorporated (company) — Registrant
- May 14, 2025 (date) — Date of Report
- 50 Northern Avenue, Boston, MA (location) — Principal executive offices
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific matters were submitted to a vote of Vertex Pharmaceuticals' security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is May 14, 2025, which is also the date of the report.
What is Vertex Pharmaceuticals' primary industry classification?
Vertex Pharmaceuticals' Standard Industrial Classification is 'Pharmaceutical Preparations [2834]'.
Where are Vertex Pharmaceuticals' principal executive offices located?
The principal executive offices are located at 50 Northern Avenue, Boston, Massachusetts 02210.
What is the company's state of incorporation?
The company is incorporated in Massachusetts.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding VERTEX PHARMACEUTICALS INC / MA (VRTX).